Home
>
National Drug Code (NDC)
>
Voraxaze
Voraxaze - 50633-210-11 - (glucarpidase)
Drug Information of Voraxaze
| Product NDC: | 50633-210 |
| Proprietary Name: | Voraxaze |
| Non Proprietary Name: | glucarpidase |
| Active Ingredient(s): | 1000 [USP'U]/1 & nbsp; glucarpidase |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Voraxaze
| Product NDC: | 50633-210 |
| Labeler Name: | BTG International Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125327 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20120401 |
Package Information of Voraxaze
| Package NDC: | 50633-210-11 |
| Package Description: | 1 VIAL in 1 CARTON (50633-210-11) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Information of Voraxaze
| NDC Code | 50633-210-11 |
| Proprietary Name | Voraxaze |
| Package Description | 1 VIAL in 1 CARTON (50633-210-11) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 50633-210 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | glucarpidase |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120401 |
| Marketing Category Name | BLA |
| Labeler Name | BTG International Inc. |
| Substance Name | GLUCARPIDASE |
| Strength Number | 1000 |
| Strength Unit | [USP'U]/1 |
| Pharmaceutical Classes |
